Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis

Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis

Abstract Background Few studies have investigated the impact of obesity on the response to tumor necrosis factor inhibitors (TNFi) in patients with axial spondyloarthritis (axSpA). The aim of our study was to investigate the impact of different body mass index (BMI) categories on TNFi response in a...

Full description

Bibliographic Details
Main Authors: Raphael Micheroli, Monika Hebeisen, Lukas M. Wildi, Pascale Exer, Giorgio Tamborrini, Jürg Bernhard, Burkhard Möller, Pascal Zufferey, Michael J. Nissen, Almut Scherer, Adrian Ciurea, on behalf of the Rheumatologists of the Swiss Clinical Quality Management Program
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Arthritis Research & Therapy
Subjects:
Axial spondyloarthritis
Ankylosing spondylitis
Obesity
TNF inhibition
Online Access:http://link.springer.com/article/10.1186/s13075-017-1372-3

Internet

http://link.springer.com/article/10.1186/s13075-017-1372-3

Similar Items